Common IssueS and Challenges
- How do you overcome the problem of lack of internal market access experience and resource?
- Are you able to launch products effectively and optimize market access (including HTAs) in a rapidly changing and complex healthcare environment in UK and Europe?
- When should you be developing a market access strategy for your product?
- Do you know what market access activities need to be undertaken to launch effectively and what will be a waste of time and effort?
- Do you need insights or support on market access issues as part of a due diligence exercise?
How Do We Make it Work?
- An initial introductory meeting to discuss the issues
- A 2-5 day review with Action Plan and next steps proposal
- Follow-up client meeting to discuss proposal and options
- Work with client to implement suggested action plan
- Optional, ongoing support to your team in terms of implementation review
- Bespoke, market access solutions for individual products
- Extensive contacts in HTA environment and pharmaceutical industry
- Proven track record with UK and Ireland HTA bodies
- Flexible approach according to company and investor needs (1-2 days per week/ 2-4 days per month)